OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!
If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.
Requested Article:
Potential impact of replacing the 13-valent pneumococcal conjugate vaccine with 15-valent or 20-valent pneumococcal conjugate vaccine in the 1 + 1 infant schedule in England: a modelling study
Yoon Hong Choi, Marta Bertran, D Litt, et al.
The Lancet Public Health (2024) Vol. 9, Iss. 9, pp. e654-e663
Open Access | Times Cited: 8
Yoon Hong Choi, Marta Bertran, D Litt, et al.
The Lancet Public Health (2024) Vol. 9, Iss. 9, pp. e654-e663
Open Access | Times Cited: 8
Showing 8 citing articles:
Economic Evaluation of Transitioning to the 20-Valent Pneumococcal Conjugate Vaccine in the Dutch Paediatric National Immunisation Programme
Esra Şükran Çakar, An Ta, Marion G. Peters, et al.
Infectious Diseases and Therapy (2025)
Open Access
Esra Şükran Çakar, An Ta, Marion G. Peters, et al.
Infectious Diseases and Therapy (2025)
Open Access
Novedades de las inmunizaciones en la edad pediátrica
Ana Isabel Dacosta Urbieta, Ángela Manzanares Casteleiro, Irene Rivero‐Calle, et al.
(2025), pp. 6-15
Closed Access
Ana Isabel Dacosta Urbieta, Ángela Manzanares Casteleiro, Irene Rivero‐Calle, et al.
(2025), pp. 6-15
Closed Access
Cost-effectiveness analysis of 21-valent pneumococcal conjugated vaccine among adults in Canada
Raphael Ximenes, Alison E. Simmons, Gebremedhin Beedemariam Gebretekle, et al.
Vaccine (2025) Vol. 54, pp. 126985-126985
Open Access
Raphael Ximenes, Alison E. Simmons, Gebremedhin Beedemariam Gebretekle, et al.
Vaccine (2025) Vol. 54, pp. 126985-126985
Open Access
A dynamic transmission model for assessing the impact of pneumococcal vaccination
Tufail Malik, Kevin Bakker, Rachel J. Oidtman, et al.
medRxiv (Cold Spring Harbor Laboratory) (2024)
Open Access | Times Cited: 1
Tufail Malik, Kevin Bakker, Rachel J. Oidtman, et al.
medRxiv (Cold Spring Harbor Laboratory) (2024)
Open Access | Times Cited: 1
New-generation pneumococcal vaccines for children
Philippe De Wals
The Lancet Public Health (2024) Vol. 9, Iss. 9, pp. e638-e639
Open Access
Philippe De Wals
The Lancet Public Health (2024) Vol. 9, Iss. 9, pp. e638-e639
Open Access
Serotype 3 Invasive Pneumococcal Disease in Tuscany Across the Eras of Conjugate Vaccines (2005-2024) and Anthropic-Driven Respiratory Virus Fluctuations
Lorenzo Lodi, Francesco Catamerò, Walter Maria Sarli, et al.
(2024)
Closed Access
Lorenzo Lodi, Francesco Catamerò, Walter Maria Sarli, et al.
(2024)
Closed Access
Optimising vaccination strategies to prevent invasive pneumococcal disease in the elderly. Which vaccine should come first?
H. Humphreys, Mary Corcoran
Clinical Microbiology and Infection (2024)
Closed Access
H. Humphreys, Mary Corcoran
Clinical Microbiology and Infection (2024)
Closed Access
Reducing the Cost of Saving Children’s Lives
Elizabeth Miller
New England Journal of Medicine (2024) Vol. 391, Iss. 21, pp. 2050-2051
Closed Access
Elizabeth Miller
New England Journal of Medicine (2024) Vol. 391, Iss. 21, pp. 2050-2051
Closed Access
